ArticleEClinicalMedicine2023

Tocilizumab in combination with a standard induction chemotherapy in acute myeloid leukaemia patients (TOCILAM study): a single-centre, single-arm, phase 1 trial.

Pierre Peterlin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.